Gene Symbol | Gene ID | Gene Info |
---|---|---|
Fosl2
|
ENSMUSG00000029135.9 | fos-like antigen 2 |
Bach2
|
ENSMUSG00000040270.10 | BTB and CNC homology, basic leucine zipper transcription factor 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_32238601_32238758 | Bach2 | 125 | 0.965132 | 0.96 | 2.0e-03 | Click! |
chr4_32248189_32248452 | Bach2 | 556 | 0.762071 | 0.93 | 8.1e-03 | Click! |
chr4_32516326_32516488 | Bach2 | 14902 | 0.204440 | 0.88 | 2.0e-02 | Click! |
chr4_32246900_32247059 | Bach2 | 785 | 0.647517 | 0.88 | 2.1e-02 | Click! |
chr4_32352966_32353117 | Bach2 | 64394 | 0.120501 | 0.87 | 2.3e-02 | Click! |
chr5_32135740_32135897 | Fosl2 | 17 | 0.969418 | 0.95 | 4.4e-03 | Click! |
chr5_32135377_32135543 | Fosl2 | 341 | 0.837828 | 0.85 | 3.2e-02 | Click! |
chr5_32136385_32136553 | Fosl2 | 296 | 0.873873 | 0.85 | 3.4e-02 | Click! |
chr5_32134757_32134911 | Fosl2 | 967 | 0.441331 | -0.83 | 4.3e-02 | Click! |
chr5_32138520_32138689 | Fosl2 | 2431 | 0.232581 | 0.82 | 4.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_46997805_46997956 | 13.75 |
Gm22791 |
predicted gene, 22791 |
12399 |
0.15 |
chr18_46998104_46998255 | 13.04 |
Gm22791 |
predicted gene, 22791 |
12698 |
0.15 |
chr2_168518274_168518450 | 10.64 |
Nfatc2 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2 |
33914 |
0.18 |
chr14_18678485_18678659 | 10.56 |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
13422 |
0.25 |
chr3_95267928_95268183 | 10.56 |
Prune1 |
prune exopolyphosphatase |
889 |
0.34 |
chr4_115607059_115607329 | 10.52 |
Cyp4a32 |
cytochrome P450, family 4, subfamily a, polypeptide 32 |
6219 |
0.14 |
chr19_53404305_53404484 | 9.38 |
8030456M14Rik |
RIKEN cDNA 8030456M14 gene |
13605 |
0.12 |
chr8_116344914_116345106 | 8.79 |
1700018P08Rik |
RIKEN cDNA 1700018P08 gene |
12051 |
0.29 |
chr17_24000452_24000718 | 8.59 |
Prss22 |
protease, serine 22 |
2485 |
0.11 |
chr18_20987436_20987590 | 8.42 |
Rnf138 |
ring finger protein 138 |
13828 |
0.19 |
chr11_86760028_86760187 | 7.68 |
Cltc |
clathrin, heavy polypeptide (Hc) |
2542 |
0.29 |
chr16_24313632_24313811 | 7.67 |
AC169509.1 |
BMP2 inducible kinase (Bmp2k) pseudogene |
23885 |
0.17 |
chr6_94166061_94166229 | 7.59 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
116880 |
0.06 |
chr9_121435690_121435841 | 7.56 |
Trak1 |
trafficking protein, kinesin binding 1 |
18531 |
0.17 |
chr6_126035696_126035896 | 7.52 |
Ntf3 |
neurotrophin 3 |
129164 |
0.05 |
chr2_170208965_170209511 | 7.10 |
Zfp217 |
zinc finger protein 217 |
61135 |
0.12 |
chr15_74892121_74892301 | 7.05 |
Ly6m |
lymphocyte antigen 6 complex, locus M |
4810 |
0.11 |
chr8_94172420_94173095 | 6.98 |
Mt2 |
metallothionein 2 |
93 |
0.88 |
chr6_126048412_126048563 | 6.97 |
Ntf3 |
neurotrophin 3 |
116473 |
0.06 |
chr10_41565244_41565415 | 6.89 |
5730435O14Rik |
RIKEN cDNA 5730435O14 gene |
2687 |
0.19 |
chr13_54101192_54101366 | 6.86 |
Sfxn1 |
sideroflexin 1 |
8568 |
0.19 |
chr8_122174102_122174253 | 6.25 |
Zfp469 |
zinc finger protein 469 |
84443 |
0.07 |
chr13_64349576_64349754 | 6.22 |
Gm47123 |
predicted gene, 47123 |
11387 |
0.1 |
chr13_45903603_45903795 | 6.22 |
Atxn1 |
ataxin 1 |
31411 |
0.17 |
chr7_112202260_112202451 | 6.19 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
23501 |
0.22 |
chr5_145982849_145983558 | 6.17 |
Cyp3a25 |
cytochrome P450, family 3, subfamily a, polypeptide 25 |
8440 |
0.13 |
chr7_49762811_49762985 | 6.15 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
3745 |
0.25 |
chr10_121521092_121521243 | 6.14 |
Gm35696 |
predicted gene, 35696 |
10769 |
0.11 |
chr2_25363590_25363748 | 6.08 |
Uap1l1 |
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
29 |
0.93 |
chr4_135950014_135950187 | 6.02 |
Hmgcl |
3-hydroxy-3-methylglutaryl-Coenzyme A lyase |
1570 |
0.21 |
chr5_139793422_139793585 | 5.91 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
1969 |
0.22 |
chr4_105319067_105319262 | 5.84 |
Gm12722 |
predicted gene 12722 |
55782 |
0.16 |
chr14_22700312_22700491 | 5.80 |
Gm7473 |
predicted gene 7473 |
74843 |
0.11 |
chr1_192061757_192061908 | 5.79 |
Traf5 |
TNF receptor-associated factor 5 |
2670 |
0.19 |
chr13_10274143_10274314 | 5.71 |
Gm26861 |
predicted gene, 26861 |
83367 |
0.08 |
chr9_65302674_65302855 | 5.67 |
Gm16218 |
predicted gene 16218 |
4845 |
0.11 |
chr3_90118489_90118660 | 5.62 |
Gm23723 |
predicted gene, 23723 |
7961 |
0.09 |
chr3_104531244_104531395 | 5.60 |
Lrig2 |
leucine-rich repeats and immunoglobulin-like domains 2 |
19401 |
0.12 |
chr2_5286550_5286732 | 5.59 |
Gm13197 |
predicted gene 13197 |
2991 |
0.3 |
chr8_126844756_126844953 | 5.58 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
5621 |
0.22 |
chr13_57346261_57346414 | 5.53 |
Gm48176 |
predicted gene, 48176 |
69659 |
0.13 |
chr17_42938590_42938768 | 5.52 |
Cd2ap |
CD2-associated protein |
62014 |
0.13 |
chr13_101632911_101633094 | 5.43 |
Gm29341 |
predicted gene 29341 |
26769 |
0.17 |
chr2_33444417_33444586 | 5.43 |
Gm13536 |
predicted gene 13536 |
2301 |
0.24 |
chr9_119266074_119266229 | 5.41 |
Oxsr1 |
oxidative-stress responsive 1 |
1379 |
0.34 |
chr6_115866425_115866588 | 5.38 |
Ift122 |
intraflagellar transport 122 |
10761 |
0.11 |
chr16_95814866_95815042 | 5.34 |
2810404F17Rik |
RIKEN cDNA 2810404F17 gene |
6637 |
0.19 |
chr10_107943872_107944134 | 5.34 |
Gm29685 |
predicted gene, 29685 |
2642 |
0.35 |
chr5_25054101_25054285 | 5.32 |
Prkag2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
46449 |
0.11 |
chr8_126613233_126613384 | 5.29 |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
19322 |
0.22 |
chr17_84116337_84116498 | 5.29 |
Gm19696 |
predicted gene, 19696 |
19543 |
0.15 |
chr6_115870588_115870749 | 5.28 |
Ift122 |
intraflagellar transport 122 |
6599 |
0.12 |
chr8_33792891_33793064 | 5.24 |
Rbpms |
RNA binding protein gene with multiple splicing |
4237 |
0.17 |
chr8_69012703_69012878 | 5.22 |
Gm33103 |
predicted gene, 33103 |
11107 |
0.17 |
chr8_126686853_126687025 | 5.21 |
Gm45805 |
predicted gene 45805 |
71395 |
0.1 |
chr16_31994081_31994256 | 5.21 |
Hmgb1-ps6 |
high mobility group box 1, pseudogene 6 |
2300 |
0.13 |
chr12_75820288_75820451 | 5.21 |
Syne2 |
spectrin repeat containing, nuclear envelope 2 |
2019 |
0.41 |
chr14_45561878_45562029 | 5.20 |
Gm15601 |
predicted gene 15601 |
1881 |
0.17 |
chr4_46304170_46304340 | 5.20 |
Gm12447 |
predicted gene 12447 |
23041 |
0.12 |
chr15_102014961_102015124 | 5.17 |
Krt8 |
keratin 8 |
10560 |
0.11 |
chr19_21106253_21106896 | 5.16 |
4930554I06Rik |
RIKEN cDNA 4930554I06 gene |
1864 |
0.42 |
chr19_38356216_38356572 | 5.12 |
Gm50150 |
predicted gene, 50150 |
13780 |
0.14 |
chr10_84701256_84701556 | 5.08 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
54656 |
0.1 |
chr13_13471592_13471780 | 5.05 |
Gm48682 |
predicted gene, 48682 |
10719 |
0.14 |
chr18_34927551_34927712 | 5.05 |
Etf1 |
eukaryotic translation termination factor 1 |
4376 |
0.14 |
chr10_84854177_84854328 | 5.02 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
16104 |
0.21 |
chr6_117604955_117605122 | 4.93 |
Gm45083 |
predicted gene 45083 |
7532 |
0.22 |
chr2_30712077_30712436 | 4.89 |
Gm14488 |
predicted gene 14488 |
4787 |
0.16 |
chr18_47313549_47313714 | 4.86 |
Sema6a |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
19695 |
0.21 |
chr11_28906435_28906594 | 4.86 |
Efemp1 |
epidermal growth factor-containing fibulin-like extracellular matrix protein 1 |
9153 |
0.23 |
chr14_34608026_34608211 | 4.81 |
Opn4 |
opsin 4 (melanopsin) |
7976 |
0.13 |
chr1_193102685_193102845 | 4.80 |
Utp25 |
UTP25 small subunit processome component |
11910 |
0.14 |
chr3_67490227_67490388 | 4.78 |
Gm42568 |
predicted gene 42568 |
13329 |
0.13 |
chr3_110579368_110579533 | 4.78 |
Gm26076 |
predicted gene, 26076 |
14909 |
0.21 |
chr15_31536046_31536238 | 4.75 |
Marchf6 |
membrane associated ring-CH-type finger 6 |
5089 |
0.14 |
chr9_119265881_119266049 | 4.75 |
Oxsr1 |
oxidative-stress responsive 1 |
1193 |
0.39 |
chr12_62877016_62877197 | 4.72 |
Gm7763 |
predicted gene 7763 |
6176 |
0.25 |
chr3_27905130_27905320 | 4.71 |
Tmem212 |
transmembrane protein 212 |
8857 |
0.22 |
chr19_29150259_29150410 | 4.70 |
Gm5518 |
predicted gene 5518 |
9784 |
0.15 |
chr13_30036706_30036863 | 4.69 |
Gm11368 |
predicted gene 11368 |
21893 |
0.17 |
chr11_97971356_97971544 | 4.66 |
Gm11633 |
predicted gene 11633 |
2658 |
0.15 |
chr14_121435885_121436040 | 4.64 |
Gm33299 |
predicted gene, 33299 |
19800 |
0.17 |
chr6_70814000_70814168 | 4.63 |
Rpia |
ribose 5-phosphate isomerase A |
21852 |
0.13 |
chr7_113242228_113242404 | 4.63 |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
2562 |
0.3 |
chr6_91488990_91489149 | 4.62 |
Tmem43 |
transmembrane protein 43 |
12469 |
0.1 |
chr1_39193049_39193247 | 4.59 |
Npas2 |
neuronal PAS domain protein 2 |
583 |
0.75 |
chr16_94544597_94544776 | 4.56 |
Vps26c |
VPS26 endosomal protein sorting factor C |
17856 |
0.16 |
chr17_23675280_23675431 | 4.54 |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
1198 |
0.16 |
chr6_126033747_126033913 | 4.52 |
Ntf3 |
neurotrophin 3 |
131130 |
0.05 |
chr12_110381296_110381622 | 4.49 |
Gm47195 |
predicted gene, 47195 |
56074 |
0.08 |
chr13_104041150_104041332 | 4.47 |
Nln |
neurolysin (metallopeptidase M3 family) |
3599 |
0.26 |
chr10_12788002_12788200 | 4.46 |
Gm23044 |
predicted gene, 23044 |
5873 |
0.23 |
chr17_70746763_70747075 | 4.44 |
5031415H12Rik |
RIKEN cDNA 5031415H12 gene |
8663 |
0.19 |
chr3_68508770_68508933 | 4.39 |
Schip1 |
schwannomin interacting protein 1 |
14643 |
0.22 |
chr11_95800638_95800832 | 4.37 |
Phospho1 |
phosphatase, orphan 1 |
23764 |
0.1 |
chr14_69728721_69728885 | 4.37 |
Chmp7 |
charged multivesicular body protein 7 |
2072 |
0.22 |
chr19_4436418_4436609 | 4.35 |
A930001C03Rik |
RIKEN cDNA A930001C03 gene |
2490 |
0.17 |
chr16_35741922_35742102 | 4.33 |
Gm25967 |
predicted gene, 25967 |
19779 |
0.13 |
chr10_12858109_12858285 | 4.31 |
Utrn |
utrophin |
3538 |
0.24 |
chr17_24365008_24365167 | 4.29 |
Abca3 |
ATP-binding cassette, sub-family A (ABC1), member 3 |
605 |
0.54 |
chr15_91690732_91690883 | 4.27 |
Lrrk2 |
leucine-rich repeat kinase 2 |
17632 |
0.22 |
chr5_117872658_117872809 | 4.26 |
Gm37028 |
predicted gene, 37028 |
80 |
0.97 |
chr6_129532538_129532722 | 4.26 |
Gabarapl1 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
530 |
0.42 |
chr1_182383191_182383342 | 4.26 |
Gm5706 |
predicted gene 5706 |
10269 |
0.15 |
chr8_3418238_3418389 | 4.23 |
Arhgef18 |
rho/rac guanine nucleotide exchange factor (GEF) 18 |
8387 |
0.15 |
chr3_27431035_27431235 | 4.22 |
Ghsr |
growth hormone secretagogue receptor |
59784 |
0.12 |
chr10_119063499_119063650 | 4.22 |
Gm33677 |
predicted gene, 33677 |
13075 |
0.14 |
chr16_30390721_30390890 | 4.18 |
Atp13a3 |
ATPase type 13A3 |
1968 |
0.36 |
chr1_184275932_184276128 | 4.17 |
Gm37223 |
predicted gene, 37223 |
82299 |
0.09 |
chr12_8400497_8400648 | 4.17 |
Gm48075 |
predicted gene, 48075 |
6363 |
0.19 |
chr6_31066838_31067230 | 4.15 |
Gm27019 |
predicted gene, 27019 |
3539 |
0.14 |
chr7_98912975_98913128 | 4.15 |
Gm45187 |
predicted gene 45187 |
7964 |
0.14 |
chr8_70702867_70703034 | 4.14 |
Iqcn |
IQ motif containing N |
507 |
0.55 |
chr13_36367851_36368002 | 4.13 |
Fars2 |
phenylalanine-tRNA synthetase 2 (mitochondrial) |
21232 |
0.22 |
chr5_52309795_52309946 | 4.13 |
Gm43179 |
predicted gene 43179 |
32490 |
0.12 |
chr17_24007509_24007674 | 4.11 |
Gm27700 |
predicted gene, 27700 |
2441 |
0.11 |
chr10_59537699_59537863 | 4.09 |
Gm10322 |
predicted gene 10322 |
78282 |
0.08 |
chr7_130968693_130968854 | 4.09 |
Htra1 |
HtrA serine peptidase 1 |
12897 |
0.19 |
chr19_27176664_27176830 | 4.08 |
Gm35438 |
predicted gene, 35438 |
15262 |
0.21 |
chr4_130075213_130075370 | 4.08 |
Col16a1 |
collagen, type XVI, alpha 1 |
1752 |
0.29 |
chr1_180021793_180021974 | 4.07 |
Gm38169 |
predicted gene, 38169 |
821 |
0.66 |
chr7_107508080_107508235 | 4.07 |
Syt9 |
synaptotagmin IX |
4061 |
0.23 |
chr16_30034134_30034429 | 4.06 |
9030404E10Rik |
RIKEN cDNA 9030404E10 gene |
5198 |
0.17 |
chr7_98108856_98109007 | 4.06 |
Myo7a |
myosin VIIA |
317 |
0.89 |
chr3_98689281_98689448 | 4.06 |
Gm12400 |
predicted gene 12400 |
1182 |
0.39 |
chr7_35303473_35303624 | 4.04 |
Gpatch1 |
G patch domain containing 1 |
14847 |
0.12 |
chr6_15726587_15726764 | 4.03 |
Mdfic |
MyoD family inhibitor domain containing |
1124 |
0.62 |
chr17_43395949_43396103 | 4.03 |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
6538 |
0.25 |
chr5_120644276_120644446 | 4.02 |
Gm42657 |
predicted gene 42657 |
2740 |
0.12 |
chr14_95928513_95928672 | 3.99 |
Gm18885 |
predicted gene, 18885 |
4368 |
0.28 |
chr11_67549406_67549557 | 3.97 |
Gas7 |
growth arrest specific 7 |
2028 |
0.38 |
chr13_63243697_63243864 | 3.96 |
Gm47586 |
predicted gene, 47586 |
441 |
0.69 |
chr8_105994175_105994329 | 3.95 |
Dpep2 |
dipeptidase 2 |
2142 |
0.12 |
chr14_47354165_47354327 | 3.94 |
Lgals3 |
lectin, galactose binding, soluble 3 |
13505 |
0.1 |
chr12_16841127_16841314 | 3.92 |
Gm36495 |
predicted gene, 36495 |
9661 |
0.14 |
chr13_92613259_92613411 | 3.92 |
Serinc5 |
serine incorporator 5 |
2161 |
0.34 |
chr1_79759581_79759745 | 3.92 |
Wdfy1 |
WD repeat and FYVE domain containing 1 |
2058 |
0.27 |
chr3_9540795_9540955 | 3.91 |
Zfp704 |
zinc finger protein 704 |
24424 |
0.2 |
chr5_49344702_49344867 | 3.91 |
Kcnip4 |
Kv channel interacting protein 4 |
59125 |
0.1 |
chr8_126826362_126826974 | 3.89 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
12565 |
0.21 |
chr11_90224957_90225225 | 3.89 |
Mmd |
monocyte to macrophage differentiation-associated |
24365 |
0.15 |
chr15_72833192_72833390 | 3.88 |
Peg13 |
paternally expressed 13 |
22967 |
0.22 |
chr7_84198740_84198963 | 3.87 |
Gm44826 |
predicted gene 44826 |
11663 |
0.14 |
chr5_134554086_134554240 | 3.86 |
Clip2 |
CAP-GLY domain containing linker protein 2 |
1729 |
0.19 |
chr13_18868301_18868479 | 3.85 |
Vps41 |
VPS41 HOPS complex subunit |
23527 |
0.19 |
chr14_8102043_8102194 | 3.85 |
Pxk |
PX domain containing serine/threonine kinase |
3863 |
0.22 |
chr10_81102537_81102688 | 3.83 |
Mir5615-2 |
microRNA 5615-2 |
2004 |
0.12 |
chr19_43896493_43896674 | 3.83 |
Dnmbp |
dynamin binding protein |
5892 |
0.15 |
chr16_45644450_45644629 | 3.81 |
Gm49585 |
predicted gene, 49585 |
2182 |
0.24 |
chr12_69215107_69215258 | 3.80 |
Pole2 |
polymerase (DNA directed), epsilon 2 (p59 subunit) |
1281 |
0.21 |
chr12_21167471_21167660 | 3.80 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
55611 |
0.1 |
chr10_120060730_120060884 | 3.80 |
Helb |
helicase (DNA) B |
31402 |
0.18 |
chr10_99555887_99556063 | 3.79 |
Gm48085 |
predicted gene, 48085 |
17906 |
0.18 |
chr5_134941937_134942100 | 3.78 |
Mettl27 |
methyltransferase like 27 |
1556 |
0.18 |
chr12_82855409_82855613 | 3.78 |
Gm22149 |
predicted gene, 22149 |
83055 |
0.09 |
chr2_59670423_59670592 | 3.77 |
Tanc1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
23696 |
0.24 |
chr5_115528254_115528453 | 3.76 |
Pxn |
paxillin |
8048 |
0.09 |
chr14_63207791_63207974 | 3.76 |
Gata4 |
GATA binding protein 4 |
5725 |
0.16 |
chr4_144955961_144956116 | 3.74 |
Gm38074 |
predicted gene, 38074 |
2810 |
0.27 |
chr1_52597910_52598075 | 3.74 |
Gm5527 |
predicted gene 5527 |
13474 |
0.13 |
chr8_91529579_91530083 | 3.74 |
Gm45290 |
predicted gene 45290 |
2893 |
0.21 |
chr8_94678714_94678865 | 3.72 |
Pllp |
plasma membrane proteolipid |
183 |
0.91 |
chr7_73589284_73589454 | 3.72 |
Gm44734 |
predicted gene 44734 |
19579 |
0.1 |
chr7_84117939_84118128 | 3.71 |
Abhd17c |
abhydrolase domain containing 17C |
29782 |
0.13 |
chr12_80832436_80832620 | 3.71 |
Susd6 |
sushi domain containing 6 |
36180 |
0.11 |
chr19_10690326_10690666 | 3.71 |
Vps37c |
vacuolar protein sorting 37C |
1731 |
0.21 |
chr11_100330372_100330542 | 3.70 |
Gast |
gastrin |
3950 |
0.09 |
chr15_4561546_4561984 | 3.70 |
C6 |
complement component 6 |
165410 |
0.03 |
chr19_4213519_4213699 | 3.69 |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
629 |
0.3 |
chr2_126591444_126591598 | 3.69 |
Hdc |
histidine decarboxylase |
6740 |
0.18 |
chr6_38961152_38961303 | 3.69 |
Tbxas1 |
thromboxane A synthase 1, platelet |
10638 |
0.18 |
chr5_146106720_146106871 | 3.68 |
Cyp3a59 |
cytochrome P450, family 3, subfamily a, polypeptide 59 |
27528 |
0.11 |
chr10_52273135_52273286 | 3.68 |
Dcbld1 |
discoidin, CUB and LCCL domain containing 1 |
39573 |
0.11 |
chr9_31851816_31851990 | 3.68 |
Gm31497 |
predicted gene, 31497 |
54090 |
0.1 |
chr5_66200133_66200302 | 3.68 |
Gm15794 |
predicted gene 15794 |
1109 |
0.34 |
chr12_111944676_111945000 | 3.68 |
5033406O09Rik |
RIKEN cDNA 5033406O09 gene |
354 |
0.78 |
chr7_25387916_25388067 | 3.67 |
Lipe |
lipase, hormone sensitive |
1233 |
0.27 |
chr3_109255070_109255263 | 3.67 |
Gm13865 |
predicted gene 13865 |
62299 |
0.11 |
chr8_116265765_116265918 | 3.65 |
4930422C21Rik |
RIKEN cDNA 4930422C21 gene |
78472 |
0.11 |
chr7_28930802_28930978 | 3.65 |
Actn4 |
actinin alpha 4 |
11669 |
0.1 |
chr2_39161075_39161269 | 3.64 |
Gm16523 |
predicted gene, 16523 |
817 |
0.5 |
chr4_88928504_88928687 | 3.64 |
Gm49890 |
predicted gene, 49890 |
9926 |
0.1 |
chr5_31036629_31036808 | 3.64 |
Slc5a6 |
solute carrier family 5 (sodium-dependent vitamin transporter), member 6 |
1276 |
0.28 |
chr5_53236217_53236384 | 3.62 |
Sel1l3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
22373 |
0.16 |
chr2_154607079_154607260 | 3.60 |
Pxmp4 |
peroxisomal membrane protein 4 |
3461 |
0.13 |
chr7_80605315_80605486 | 3.59 |
Gm44931 |
predicted gene 44931 |
1617 |
0.32 |
chr17_84148940_84149109 | 3.59 |
Gm19696 |
predicted gene, 19696 |
7402 |
0.17 |
chrX_75834438_75834605 | 3.59 |
Pls3 |
plastin 3 (T-isoform) |
7568 |
0.19 |
chr10_20673746_20674078 | 3.56 |
Gm17230 |
predicted gene 17230 |
48277 |
0.14 |
chr10_8088798_8088960 | 3.55 |
Gm48614 |
predicted gene, 48614 |
67587 |
0.11 |
chr10_8870490_8870690 | 3.55 |
4930553I21Rik |
RIKEN cDNA 4930553I21 gene |
9147 |
0.15 |
chr5_146107597_146107748 | 3.54 |
Cyp3a59 |
cytochrome P450, family 3, subfamily a, polypeptide 59 |
28405 |
0.11 |
chr11_94636935_94637155 | 3.54 |
Lrrc59 |
leucine rich repeat containing 59 |
7231 |
0.1 |
chr10_77434735_77434942 | 3.54 |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
16568 |
0.16 |
chr19_4441877_4442205 | 3.54 |
A930001C03Rik |
RIKEN cDNA A930001C03 gene |
1697 |
0.23 |
chr18_82910531_82910682 | 3.52 |
Zfp516 |
zinc finger protein 516 |
57 |
0.97 |
chr17_28925057_28925224 | 3.51 |
Gm16191 |
predicted gene 16191 |
323 |
0.76 |
chr2_145686140_145686298 | 3.51 |
Rin2 |
Ras and Rab interactor 2 |
10852 |
0.21 |
chr9_70842518_70842680 | 3.51 |
Gm3436 |
predicted pseudogene 3436 |
9977 |
0.21 |
chr3_18069154_18069305 | 3.51 |
Gm23726 |
predicted gene, 23726 |
97 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 6.4 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.2 | 3.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.2 | 3.5 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
1.1 | 6.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
1.1 | 3.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.0 | 3.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.9 | 2.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.9 | 2.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.9 | 2.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.8 | 4.2 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.8 | 2.5 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.8 | 2.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.7 | 2.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.7 | 2.2 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.7 | 2.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.7 | 4.3 | GO:0051775 | response to redox state(GO:0051775) |
0.7 | 3.4 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.7 | 2.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.7 | 1.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.6 | 1.9 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.6 | 3.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 1.9 | GO:0015817 | histidine transport(GO:0015817) |
0.6 | 1.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.6 | 4.7 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.6 | 2.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.6 | 1.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.6 | 1.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 1.7 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.6 | 1.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.5 | 1.1 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.5 | 4.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.5 | 0.5 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.5 | 2.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.5 | 1.5 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 3.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.5 | 0.5 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.5 | 1.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 1.5 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.5 | 1.9 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.5 | 1.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 2.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.4 | 1.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.4 | 2.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.4 | 1.3 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.4 | 1.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 1.3 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 2.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.4 | 1.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 1.2 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.4 | 2.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 2.8 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.4 | 0.8 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.4 | 1.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.4 | 0.8 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.4 | 1.5 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
0.4 | 1.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.4 | 1.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 2.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 1.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.4 | 1.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 0.7 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.4 | 0.7 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.4 | 1.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 1.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 3.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 0.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 1.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 1.7 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.3 | 1.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.3 | 0.3 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.3 | 3.0 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.3 | 2.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 1.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 0.7 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.3 | 1.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 1.6 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.3 | 1.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 2.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 1.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.3 | 1.0 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.3 | 0.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 1.6 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.3 | 2.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 1.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 0.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 1.2 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 0.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 1.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 0.6 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.3 | 2.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 2.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 1.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 0.9 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 1.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 0.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 1.2 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 1.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 1.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 0.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 0.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.3 | 0.9 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.3 | 3.1 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.3 | 0.8 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.3 | 3.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.3 | 0.6 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.3 | 0.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.3 | 1.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 0.6 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.3 | 1.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 0.3 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.3 | 1.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.3 | 0.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.3 | 1.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 0.3 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.3 | 0.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.8 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 1.9 | GO:0070417 | cellular response to cold(GO:0070417) |
0.3 | 0.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 3.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 0.5 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 0.8 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.3 | 0.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 0.3 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.3 | 0.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 1.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.3 | 1.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 0.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 1.0 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 0.7 | GO:0032342 | aldosterone biosynthetic process(GO:0032342) |
0.2 | 0.7 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.7 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.2 | 0.7 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.7 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 1.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 1.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 0.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.2 | 0.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.5 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 1.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.7 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 0.7 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.2 | 2.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 1.2 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 0.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 1.6 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 0.5 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 1.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.7 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.7 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.4 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.2 | 0.7 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 0.9 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.2 | 0.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.6 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 0.2 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.2 | 0.4 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 0.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.2 | 3.2 | GO:0009409 | response to cold(GO:0009409) |
0.2 | 0.6 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.2 | 0.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.6 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 0.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 2.0 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 0.4 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.2 | 0.4 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 | 1.6 | GO:0042637 | catagen(GO:0042637) |
0.2 | 1.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.2 | 0.2 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 0.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.2 | 4.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 1.6 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.2 | 0.6 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.2 | 2.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.6 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.2 | 1.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.8 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 1.7 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 3.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.7 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.2 | 0.7 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.2 | 2.6 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.4 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
0.2 | 0.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.4 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) regulation of eosinophil activation(GO:1902566) |
0.2 | 0.6 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.2 | 0.2 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.2 | 0.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 1.8 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.2 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.2 | 1.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.5 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 0.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 1.2 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.2 | 0.7 | GO:0035106 | operant conditioning(GO:0035106) |
0.2 | 1.4 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.2 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.2 | 1.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 0.9 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.2 | 0.7 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 1.9 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 1.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.2 | 1.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 0.3 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.2 | 0.3 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 2.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.2 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.2 | 0.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.2 | 0.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 0.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 0.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 0.5 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.2 | 0.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.2 | 0.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.2 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.2 | 0.7 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.2 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.3 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.2 | 0.3 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.2 | 1.0 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 1.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 1.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 1.6 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 1.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 0.3 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.2 | 0.3 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.2 | 0.3 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 0.6 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 0.3 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 0.5 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.2 | 2.0 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.2 | 0.3 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 0.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.2 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 0.2 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.2 | 0.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 1.8 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 0.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 0.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 1.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 0.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 1.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.2 | 3.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.3 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 0.5 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 3.0 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 2.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.3 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.4 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 1.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.4 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.4 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.9 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 1.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.3 | GO:0090500 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
0.1 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 0.9 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.1 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.1 | 0.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 0.8 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.7 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.7 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 1.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 1.9 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.1 | 0.5 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.1 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.1 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.5 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.1 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.1 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.1 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.1 | 0.7 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.1 | 0.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 1.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 0.9 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 2.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.1 | 0.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 1.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.4 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 1.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 1.4 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 0.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.2 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.1 | 0.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 2.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 1.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.4 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.1 | 0.2 | GO:0035768 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.1 | 0.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 1.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.6 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.7 | GO:0071715 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.1 | 0.8 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.1 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.1 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 0.2 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 0.5 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 0.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.2 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.1 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.1 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.1 | 0.3 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 0.4 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.1 | 0.2 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.1 | 0.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.6 | GO:0044321 | response to leptin(GO:0044321) |
0.1 | 0.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.3 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.9 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.4 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.6 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.6 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 1.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 2.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.3 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
0.1 | 1.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.4 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.2 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.2 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.1 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.5 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.2 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) response to pyrethroid(GO:0046684) |
0.1 | 0.2 | GO:1900094 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.1 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.1 | GO:0072497 | mesenchymal stem cell differentiation(GO:0072497) regulation of mesenchymal stem cell differentiation(GO:2000739) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.6 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.3 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.9 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 2.5 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.1 | 0.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.1 | GO:1903416 | response to glycoside(GO:1903416) |
0.1 | 0.6 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 1.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.2 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 1.9 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.3 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.1 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.1 | 0.1 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.8 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 0.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.1 | 0.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.6 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.6 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.5 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.9 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 2.9 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.2 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.1 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.8 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.3 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.5 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.3 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.8 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.2 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.2 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.1 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.6 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 1.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.2 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.1 | 0.2 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.1 | 0.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.7 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.1 | 0.3 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.7 | GO:0002192 | cap-independent translational initiation(GO:0002190) IRES-dependent translational initiation(GO:0002192) |
0.1 | 0.3 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.6 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.9 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.3 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.3 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.2 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.8 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 0.4 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.3 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.4 | GO:1902287 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.4 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 0.2 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.4 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.1 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.9 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 1.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.5 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.2 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 0.2 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) |
0.1 | 0.9 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.2 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.2 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.1 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.1 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.4 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.7 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.1 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) |
0.1 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.1 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.6 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.4 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.5 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.7 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.7 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 3.1 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 1.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.2 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.6 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.1 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.1 | 0.1 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.1 | 0.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.1 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.3 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.1 | 0.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 1.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 3.6 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 0.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.4 | GO:0036230 | granulocyte activation(GO:0036230) |
0.1 | 0.4 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.4 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 1.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.5 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.1 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.2 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 2.6 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.1 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 1.8 | GO:0031060 | regulation of histone methylation(GO:0031060) |
0.1 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.4 | GO:0050802 | circadian sleep/wake cycle, sleep(GO:0050802) |
0.1 | 0.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.1 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 1.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.2 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.1 | GO:0086011 | membrane repolarization during action potential(GO:0086011) regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.5 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.1 | 0.2 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.1 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
0.1 | 0.5 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.1 | 0.4 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.2 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.6 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.1 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.1 | 0.2 | GO:0019883 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) |
0.1 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 2.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.1 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 1.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.2 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.6 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.3 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.1 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.1 | 0.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.4 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.1 | 0.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.1 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.1 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.1 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.1 | 0.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.1 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.1 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.6 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.1 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.2 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.1 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 1.8 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.1 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.1 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.1 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.3 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 0.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 1.5 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.5 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.5 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.1 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.1 | 1.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.2 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.1 | GO:0051340 | regulation of ligase activity(GO:0051340) |
0.1 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 1.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.1 | 0.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.4 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.2 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.2 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.1 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.2 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.7 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.6 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.8 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 0.7 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.0 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.0 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.4 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 0.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.1 | GO:0002892 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.0 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.1 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.5 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.7 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.2 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.0 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.0 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.0 | 0.2 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.3 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
0.0 | 0.0 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.0 | 0.1 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.3 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 2.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.0 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.0 | 1.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.7 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.1 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.0 | 0.2 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 1.6 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.0 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.0 | 0.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.0 | 0.0 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.0 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.2 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.1 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.0 | 0.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.0 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 | 1.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.0 | 0.4 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.0 | GO:0071879 | regulation of adrenergic receptor signaling pathway(GO:0071877) positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.0 | 0.4 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.0 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.8 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 1.1 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.4 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.0 | 0.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.3 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.1 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.5 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.2 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.0 | 0.1 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.0 | 0.3 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.0 | 0.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.1 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.0 | 0.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.0 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.0 | 0.1 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.0 | 0.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 1.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.1 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.0 | 0.1 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.1 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.0 | 0.1 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.0 | 0.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 0.1 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
0.0 | 0.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.0 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.0 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.4 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.0 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 0.0 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.0 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.2 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.1 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.0 | 0.1 | GO:0044359 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.0 | GO:0014874 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 0.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.1 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.0 | 0.2 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.0 | 0.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.5 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0051127 | regulation of actin nucleation(GO:0051125) positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.3 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.0 | 0.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.2 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.0 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.0 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.0 | 0.1 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.0 | 0.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.2 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.2 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.8 | GO:0006497 | protein lipidation(GO:0006497) |
0.0 | 0.0 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.0 | 0.3 | GO:0010717 | regulation of epithelial to mesenchymal transition(GO:0010717) |
0.0 | 0.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.0 | 0.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.0 | 1.0 | GO:0031333 | negative regulation of protein complex assembly(GO:0031333) |
0.0 | 0.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.0 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.0 | 0.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.3 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.2 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.0 | 0.3 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.0 | 0.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.0 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.0 | 0.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.5 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.2 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.0 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.0 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.1 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.0 | 0.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.6 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.0 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.0 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.0 | 0.9 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.1 | GO:0045191 | regulation of isotype switching(GO:0045191) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.0 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.0 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.0 | 0.0 | GO:1902991 | regulation of amyloid precursor protein catabolic process(GO:1902991) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.0 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.3 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 1.4 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.0 | 0.1 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.4 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.6 | GO:0002761 | regulation of myeloid leukocyte differentiation(GO:0002761) |
0.0 | 0.1 | GO:0043368 | positive T cell selection(GO:0043368) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.0 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.1 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.1 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.0 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.1 | GO:0090342 | regulation of cell aging(GO:0090342) |
0.0 | 0.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 0.0 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.2 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.0 | 0.2 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.3 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.0 | 0.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.1 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.0 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.1 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.2 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.1 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.0 | GO:1901563 | response to camptothecin(GO:1901563) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.1 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.1 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.0 | 0.0 | GO:0051383 | kinetochore organization(GO:0051383) |
0.0 | 0.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.0 | GO:0097484 | dendrite extension(GO:0097484) |
0.0 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.0 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 0.1 | GO:0060384 | innervation(GO:0060384) |
0.0 | 0.0 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) regulation of chloride transport(GO:2001225) |
0.0 | 0.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.5 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.0 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.0 | 0.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.0 | GO:0035810 | regulation of urine volume(GO:0035809) positive regulation of urine volume(GO:0035810) |
0.0 | 0.8 | GO:1903214 | regulation of protein targeting to mitochondrion(GO:1903214) |
0.0 | 0.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.0 | 0.4 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.0 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.0 | 0.0 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.0 | 0.0 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.0 | 0.2 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.2 | GO:0048066 | developmental pigmentation(GO:0048066) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.0 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.0 | 0.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.0 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 0.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.0 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.0 | 0.1 | GO:0002931 | response to ischemia(GO:0002931) |
0.0 | 0.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.0 | GO:0008090 | retrograde axonal transport(GO:0008090) late endosome to lysosome transport(GO:1902774) |
0.0 | 0.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.0 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.0 | 0.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.0 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.0 | 0.0 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.1 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 0.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.0 | 0.0 | GO:0035268 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.0 | 0.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.0 | GO:0006304 | DNA modification(GO:0006304) |
0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.1 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0035090 | maintenance of cell polarity(GO:0030011) maintenance of apical/basal cell polarity(GO:0035090) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.0 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.0 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.0 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.0 | 0.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.0 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.0 | GO:0044851 | anagen(GO:0042640) hair cycle phase(GO:0044851) |
0.0 | 0.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.0 | GO:0046878 | regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.0 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.7 | GO:0031523 | Myb complex(GO:0031523) |
0.9 | 2.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.7 | 2.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.6 | 2.3 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.6 | 1.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 1.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.5 | 1.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.4 | 2.6 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.4 | 2.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 0.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.4 | 1.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 1.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 1.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 2.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 3.3 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 1.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 2.9 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 0.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 1.4 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 2.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 0.9 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 2.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 2.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 1.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 0.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 3.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 1.5 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 2.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 1.5 | GO:0005767 | secondary lysosome(GO:0005767) |
0.2 | 1.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 0.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 1.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 0.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 0.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 1.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 0.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 1.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 0.8 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 1.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 4.4 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 1.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 1.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.5 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.9 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 2.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.3 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.8 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 1.0 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 6.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 1.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 2.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 1.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.1 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.6 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 1.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 3.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.6 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.6 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.3 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 1.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 3.1 | GO:0005844 | polysome(GO:0005844) |
0.1 | 1.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 1.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.7 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 6.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.3 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 2.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 2.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 1.7 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 6.9 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.6 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 1.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 1.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 1.9 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 2.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.9 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.7 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 3.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.8 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 2.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.7 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.8 | GO:0001741 | XY body(GO:0001741) |
0.1 | 2.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.2 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 2.3 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 0.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 1.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.7 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.4 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.7 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 2.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 4.7 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 1.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 4.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.2 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 3.1 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.7 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 2.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 1.0 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 2.5 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 1.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.4 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 1.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 2.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 6.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.9 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 3.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.4 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 1.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.0 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0071010 | prespliceosome(GO:0071010) |
0.0 | 0.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.0 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.1 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.1 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.2 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.4 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.9 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.3 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.8 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.2 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.0 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.1 | GO:0030894 | replisome(GO:0030894) |
0.0 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.0 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.6 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.1 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 0.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 0.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.9 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.0 | GO:0000796 | condensin complex(GO:0000796) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 1.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.3 | 4.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.9 | 5.5 | GO:0043338 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.9 | 4.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.9 | 2.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.9 | 3.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.7 | 2.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.7 | 2.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.7 | 0.7 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.7 | 4.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 2.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 3.6 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.6 | 1.8 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 4.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 1.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 2.4 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.5 | 1.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.5 | 1.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 3.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 1.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.4 | 1.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 1.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 1.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 1.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.4 | 1.2 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.4 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 1.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 1.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.3 | 1.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 2.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 1.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 0.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.3 | 1.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 1.2 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.3 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 0.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 1.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 1.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 0.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 1.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 1.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 0.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 3.9 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 1.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.3 | 1.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 3.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 0.8 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 1.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 1.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 0.8 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.3 | 3.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 0.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 0.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.3 | 2.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 1.3 | GO:0070061 | fructose binding(GO:0070061) |
0.3 | 1.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 1.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 1.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 1.7 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 1.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 2.0 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 0.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 1.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 0.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 1.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 0.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 1.5 | GO:0018632 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) tocotrienol omega-hydroxylase activity(GO:0052872) thalianol hydroxylase activity(GO:0080014) |
0.2 | 0.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 1.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.2 | 1.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 0.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 0.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 1.0 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 1.6 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 0.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.6 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 1.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 1.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 2.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 1.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 1.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 1.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.9 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 1.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 4.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 0.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 2.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 2.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.5 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 2.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 3.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 1.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 1.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 0.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 1.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 0.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 1.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 1.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 1.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 1.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 2.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 1.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.9 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 2.3 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.2 | 0.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 0.5 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 0.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.6 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 0.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 1.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 0.9 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.2 | 0.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 4.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.6 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 2.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 1.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 1.0 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.8 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.3 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 0.5 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.1 | 0.1 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 1.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 2.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 1.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 2.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 1.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.6 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.4 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 8.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 1.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.3 | GO:0070694 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.7 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 1.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.1 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.1 | 0.9 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.3 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 2.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.3 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 2.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 2.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.3 | GO:0043919 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 0.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.1 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
0.1 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.2 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 1.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 2.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.8 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 1.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 18.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 2.0 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 8.6 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 1.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.1 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 1.1 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 2.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.5 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.5 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 4.4 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 5.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.9 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.3 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.2 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.2 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.9 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.2 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.1 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 1.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.5 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 1.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.5 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.6 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 2.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 2.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 2.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.1 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.1 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.2 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.5 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) cadmium ion binding(GO:0046870) |
0.1 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.4 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 1.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.1 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.2 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 2.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.5 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 1.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 1.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.3 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 3.5 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 1.1 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.1 | 1.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.5 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 3.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.2 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.1 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.1 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.1 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.1 | 1.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 1.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.0 | GO:0086056 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.4 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 1.3 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 2.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 1.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.0 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.0 | GO:0090484 | drug transporter activity(GO:0090484) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.0 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 6.0 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.0 | 1.5 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 1.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 1.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 0.2 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.0 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.5 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.0 | 0.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.6 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.0 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 5.7 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 1.8 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.2 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.4 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.4 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.0 | 1.0 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.2 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 2.0 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.5 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 8.9 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.5 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 1.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 2.2 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.3 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 0.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.1 | GO:0016775 | protein histidine kinase activity(GO:0004673) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 1.5 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 3.3 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.3 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.0 | 0.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.2 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) |
0.0 | 0.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 1.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.3 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.2 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.0 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.0 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 1.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.9 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.0 | 0.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 1.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.4 | GO:0052693 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.9 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 1.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 1.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.3 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.0 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.0 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.0 | 0.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.0 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.0 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 6.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 1.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 3.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 4.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 9.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 5.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 1.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 6.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 4.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 1.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 1.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 4.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 4.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 1.3 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 2.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 2.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 1.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 4.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 2.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 2.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.3 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 3.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 1.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 6.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 5.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 1.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 3.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 13.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.3 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 2.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 2.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 5.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 2.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 3.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 1.9 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 2.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 3.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 3.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 5.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 0.2 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.2 | 1.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 0.2 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.2 | 1.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 3.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 1.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 1.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 1.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 1.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 2.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 3.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 2.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 3.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 4.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 2.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.8 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.8 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 2.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 2.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 6.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 4.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.6 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 3.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 1.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 3.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 2.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 3.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 1.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 5.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 2.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 1.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 2.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 2.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.9 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION | Genes involved in TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
0.1 | 0.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 5.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 2.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 1.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 3.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 2.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.8 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 3.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 1.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.2 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.3 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 2.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 2.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME IMMUNE SYSTEM | Genes involved in Immune System |
0.0 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.7 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 1.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 3.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.4 | REACTOME TRANSCRIPTION | Genes involved in Transcription |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.2 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.0 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.0 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.0 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
0.0 | 0.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |